October 6, 2026
A German-Serbian research project led by DZL scientist Dr. Stefan Hadzic is investigating how altered proteins contribute to COPD severity and progression – and how the resulting misguided immune response could be selectively blocked.
Read moreSeptember 25, 2026
A research team from Justus Liebig University Giessen (JLU) has achieved a major success: the team behind the medical software “Hemodynamix” has won first place in the Hessian start-up competition “Hessen Ideen.”
Read moreSeptember 24, 2026
A therapeutic principle rooted in decades of pulmonary vascular research is entering a new stage of clinical development.
Read moreSeptember 15, 2026
A team of researchers from the German Center for Lung Research (DZL) has elucidated a previously poorly understood mechanism of tumor regulation: itaconate, a metabolic intermediate produced by certain immune cells, can influence the metabolism of lung cancer cells and tumor-associated macrophages, thereby inhibiting tumor growth.
Read moreSeptember 9, 2026
How does our body respond to a viral infection – and what long-term changes can an infection trigger in tissues? The new European doctoral network “MERIT” (MEtabolic Reprogramming in viral pathogenesis: From Infection to Therapeutic innovations) is investigating these questions from a holistic perspective.
Read moreJuly 10, 2026
On 25 June 2026, the Center for Interstitial and Rare Lung Diseases (ZISL) at Justus Liebig University Giessen hosted the CME-certified online symposium “ABCDE of ILD”.
Read moreJuly 3, 2026
Prof. Dr. Soni Savai Pullamsetti has been awarded a European Research Council (ERC) Proof of Concept Grant.
Read moreJune 17, 2026
More than 700 participants, vibrant scientific discussions, and a shared vision for the future of respiratory research: from 9 to 11 June 2026, the nationwide network of the German Center for Lung Research (DZL) gathered in Wiesbaden for the 14th DZL Annual Meeting.
Read moreMay 28, 2026
Idiopathic pulmonary fibrosis (IPF) is one of the most severe chronic lung diseases. It leads to progressive scarring of lung tissue and increasingly impairs breathing.
Read moreMay 12, 2026
From April 28 to 30, 2026, researchers, clinicians, and data scientists gathered at Schloss Rauischholzhausen for the DZL DataLung Symposium.
Read moreMay 11, 2026
International experts in clinical, translational, and basic science research gathered in Giessen, Germany, from May 6–8, 2026, for the eurILDreg Symposium “Re-shaping eurILDreg: structure, organisation, research goals” to discuss current developments and future strategies in the field of interstitial lung diseases (ILDs).
Read moreApril 22, 2026
A recent scientific statement from the American Heart Association, published in the journal Circulation, places greater emphasis on right ventricular function in both research and clinical care for pulmonary hypertension (PH).
Read moreMarch 26, 2026
The German Respiratory Society (DGP) has appointed five new honorary members as part of its congress. Among them are Prof. Dr. med. Werner Seeger, Chairman of the Board and Speaker of the German Center for Lung Research (DZL), and Prof. Dr. med. Claus Vogelmeier, Principal Investigator at the DZL.
Read moreMarch 24, 2026
Success for pulmonary hypertension research at the German Center for Lung Research (DZL): Two DZL scientists have been awarded the prestigious René Baumgart Foundation Research Prize.
Read moreMarch 19, 2026
Dr. Christina Malainou, a researcher at the German Center for Lung Research (DZL) and scientific coordinator in the Disease Area Pneumonia & Acute Lung Injury, has been awarded the Research Prize for Experimental Pneumology 2026 at the congress of the German Respiratory Society (DGP).
Read moreMarch 6, 2026
Fibrosing lung diseases (also referred to as “interstitial lung diseases”, ILD, or “diffuse parenchymal lung diseases”, DPLD) are rare pulmonary disorders characterized by a wide range of triggering factors (such as dust exposure, radiation, acute inflammatory, rheumatic, drug-related, or idiopathic causes), a heterogeneous clinical course, and in many cases progressive scarring of the lung.
Read moreMarch 2, 2026
The Von Behring-Röntgen Stiftung has announced its 2026 funding decisions, supporting eight innovative biomedical research projects at Philipps-Universität Marburg and Justus-Liebig-Universität Gießen.
Read moreFebruary 27, 2026
Researchers at Philipps-Universität Marburg have uncovered why the chronic lung disease COPD often worsens acutely during influenza infections: the signaling molecule CXCL11 is produced in increased amounts in response to the viral infection and disrupts the balance of the airways.
Read moreFebruary 20, 2026
Scientists from the German Center for Lung Research (DZL) gathered at the Pulmonary Vascular Research Institute (PVRI) Congress 2026 in Dublin, Ireland, to share cutting-edge findings and clinical advancements in pulmonary vascular diseases (PVDs).
Read moreFebruary 11, 2026
How the lung regenerates after injury and the role played by specific cell types are at the center of a recent review article by a group of DZL researchers.
Read moreMore news can be found on the DZL news site. The link below leads to a pre-filtered overview of all UGMLC-related news.
